SWOT Analysis for Zydus Lifesciences Ltd.

Stocks in Buy Zone with High Momentum Score Last Month
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Newly Affordable Stocks with Good Financials and Durability (subscription)
Undervalued Growth Stocks
Jim Slater's Zulu Principle (Discover Growth Stocks)
Consistent Highest Return Stocks over Five Years - Nifty500
Mid-range Performer (DVM)
Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)
Companies with high TTM EPS Growth
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Near 52 Week Low
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter

Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Companies with improving valuation scores after share price falls
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months